These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 19542190

  • 1. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro.
    McLarty J, Bigelow RL, Smith M, Elmajian D, Ankem M, Cardelli JA.
    Cancer Prev Res (Phila); 2009 Jul; 2(7):673-82. PubMed ID: 19542190
    [Abstract] [Full Text] [Related]

  • 2. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.
    Adhami VM, Siddiqui IA, Ahmad N, Gupta S, Mukhtar H.
    Cancer Res; 2004 Dec 01; 64(23):8715-22. PubMed ID: 15574782
    [Abstract] [Full Text] [Related]

  • 3. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer.
    Miyata Y, Sakai H, Hayashi T, Kanetake H.
    Prostate; 2003 Feb 01; 54(2):125-32. PubMed ID: 12497585
    [Abstract] [Full Text] [Related]

  • 4. Interrelationships between dietary restriction, the IGF-I axis, and expression of vascular endothelial growth factor by prostate adenocarcinoma in rats.
    Powolny AA, Wang S, Carlton PS, Hoot DR, Clinton SK.
    Mol Carcinog; 2008 Jun 01; 47(6):458-65. PubMed ID: 18058807
    [Abstract] [Full Text] [Related]

  • 5. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
    Hong SK, Han BK, Jeong JS, Jeong SJ, Moon KH, Byun SS, Lee SE.
    Asian J Androl; 2008 Mar 01; 10(2):207-13. PubMed ID: 18097534
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A, Schally AV, Letsch M, Krupa M, Hebert F, Busto R, Groot K, Varga JL.
    Prostate; 2002 Aug 01; 52(3):173-82. PubMed ID: 12111694
    [Abstract] [Full Text] [Related]

  • 7. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
    Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Pasha FS, Saleem M, Mukhtar H.
    Clin Cancer Res; 2007 Mar 01; 13(5):1611-9. PubMed ID: 17332308
    [Abstract] [Full Text] [Related]

  • 8. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
    Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.
    Cancer Res; 2003 Jul 15; 63(14):3991-4. PubMed ID: 12873996
    [Abstract] [Full Text] [Related]

  • 9. [Vascular endothelial growth factor and insulin-like-growth factors in prostate cancer. ].
    Trapeznikova MF, Shibaeva AN, Ianshin AA, Urenkov SB, Mironova OS, Kazantseva IA, Kushlinskiĭ NE.
    Urologiia; 2004 Jul 15; (1):17-21. PubMed ID: 15022438
    [Abstract] [Full Text] [Related]

  • 10. Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
    Oliver SE, Holly J, Peters TJ, Donovan J, Persad R, Gillatt D, Pearce A, Hamdy FC, Neal DE, Gunnell D.
    Urology; 2004 Aug 15; 64(2):317-22. PubMed ID: 15302487
    [Abstract] [Full Text] [Related]

  • 11. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ, Baxter RC.
    Clin Endocrinol (Oxf); 1997 Mar 15; 46(3):333-42. PubMed ID: 9156044
    [Abstract] [Full Text] [Related]

  • 12. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT, Le H, McFann KK, Blackman MR.
    Am J Physiol Endocrinol Metab; 2005 Mar 15; 288(3):E573-84. PubMed ID: 15536203
    [Abstract] [Full Text] [Related]

  • 13. Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer.
    George DJ, Regan MM, Oh WK, Tay MH, Manola J, Decalo N, Duggan S, Dewolf WC, Kantoff PW, Bubley GJ.
    Urology; 2004 Feb 15; 63(2):327-32. PubMed ID: 14972483
    [Abstract] [Full Text] [Related]

  • 14. The prognostic value of vascular endothelial growth factor (VEGF)-A and its receptor in clinically localized prostate cancer: a prospective evaluation in 100 patients undergoing radical prostatectomy.
    Mao K, Badoual C, Camparo P, Delongchamps NB, Vieillefond A, Dinh-Xuan AT, Peyromaure M.
    Can J Urol; 2008 Oct 15; 15(5):4257-62. PubMed ID: 18814815
    [Abstract] [Full Text] [Related]

  • 15. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
    Severi G, Morris HA, MacInnis RJ, English DR, Tilley WD, Hopper JL, Boyle P, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2006 Jun 15; 15(6):1137-41. PubMed ID: 16775172
    [Abstract] [Full Text] [Related]

  • 16. Effect of the synthetic retinoid fenretinide on circulating free prostate-specific antigen, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 levels in men with superficial bladder cancer.
    Serrano D, Baglietto L, Johansson H, Mariette F, Torrisi R, Onetto M, Paganuzzi M, Decensi A.
    Clin Cancer Res; 2005 Mar 01; 11(5):2083-8. PubMed ID: 15756035
    [Abstract] [Full Text] [Related]

  • 17. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
    Shimizu M, Deguchi A, Hara Y, Moriwaki H, Weinstein IB.
    Biochem Biophys Res Commun; 2005 Sep 02; 334(3):947-53. PubMed ID: 16053920
    [Abstract] [Full Text] [Related]

  • 18. Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells.
    Ren F, Zhang S, Mitchell SH, Butler R, Young CY.
    Oncogene; 2000 Apr 06; 19(15):1924-32. PubMed ID: 10773882
    [Abstract] [Full Text] [Related]

  • 19. [Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].
    Tang XD, Zhou X, Zhang QZ, Le AD, Zhou KY.
    Zhonghua Yi Xue Za Zhi; 2008 Nov 04; 88(40):2872-7. PubMed ID: 19080502
    [Abstract] [Full Text] [Related]

  • 20. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K, Yang J, Peleg S, Sikes CR, Kreimann EL, Daliani D, Olive M, Raymond KA, Janus TJ, Logothetis CJ, Karsenty G, Navone NM.
    Clin Cancer Res; 2003 Jul 04; 9(7):2587-97. PubMed ID: 12855635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.